D N Kiosses1, G S Alexopoulos. 1. Weill Cornell Institute of Geriatric Psychiatry, Weill Medical College of Cornell University, White Plains, NY 10605, USA. dkiosses@med.cornell.edu
Abstract
BACKGROUND: Attainment of remission is viewed as the optimal outcome of acute antidepressant treatment. However, some patients experience subsyndromal symptoms after they achieve remission. This study examines the prognostic significance of subsyndromal symptoms occurring during the first 6 months after remission of late-life depression. METHOD: Older (age 60-89 years) in-patients and out-patients with unipolar major depression were followed until remission (asymptomatic or almost asymptomatic for 3 consecutive weeks). Two hundred and forty-two achieved remission after uncontrolled antidepressant treatment. This analysis focused on remitted patients who had follow-up data over a 2.5-year period (n = 185). RESULTS: Approximately 18% of patients relapsed. Of the remainder (n = 152), 42.8% had subsyndromal depressive symptoms during the 6 months following remission. Cox's proportional survival analysis demonstrated that longer duration of subsyndromal symptoms [number of weeks with the Longitudinal Follow-up Examination (LIFE) Psychiatric Status Rating Scale (PSR) score of 3 or 4] in the first 6 months after remission was significantly associated with shorter time to recurrence and higher recurrence rate [hazard ratio (HR) 1.16, 95% confidence interval (CI) 1.08-1.24]. Based on our analysis, patients with 0, 4, 8 and 12 weeks of subsyndromal symptoms in the first 6 months after remission have estimated recurrence rates of 28, 45, 66 and 86% respectively during the ensuing 2 years. CONCLUSIONS: These findings highlight the clinical importance of subsyndromal symptoms occurring after remission in late-life depression. They also argue that studies of geriatric depression may complement the definition of remission with information on subsyndromal symptoms occurring after the initial asymptomatic period.
BACKGROUND: Attainment of remission is viewed as the optimal outcome of acute antidepressant treatment. However, some patients experience subsyndromal symptoms after they achieve remission. This study examines the prognostic significance of subsyndromal symptoms occurring during the first 6 months after remission of late-life depression. METHOD: Older (age 60-89 years) in-patients and out-patients with unipolar major depression were followed until remission (asymptomatic or almost asymptomatic for 3 consecutive weeks). Two hundred and forty-two achieved remission after uncontrolled antidepressant treatment. This analysis focused on remitted patients who had follow-up data over a 2.5-year period (n = 185). RESULTS: Approximately 18% of patients relapsed. Of the remainder (n = 152), 42.8% had subsyndromal depressive symptoms during the 6 months following remission. Cox's proportional survival analysis demonstrated that longer duration of subsyndromal symptoms [number of weeks with the Longitudinal Follow-up Examination (LIFE) Psychiatric Status Rating Scale (PSR) score of 3 or 4] in the first 6 months after remission was significantly associated with shorter time to recurrence and higher recurrence rate [hazard ratio (HR) 1.16, 95% confidence interval (CI) 1.08-1.24]. Based on our analysis, patients with 0, 4, 8 and 12 weeks of subsyndromal symptoms in the first 6 months after remission have estimated recurrence rates of 28, 45, 66 and 86% respectively during the ensuing 2 years. CONCLUSIONS: These findings highlight the clinical importance of subsyndromal symptoms occurring after remission in late-life depression. They also argue that studies of geriatric depression may complement the definition of remission with information on subsyndromal symptoms occurring after the initial asymptomatic period.
Authors: M P Taylor; C F Reynolds; E Frank; C Cornes; M D Miller; J A Stack; A E Begley; S Mazumdar; M A Dew; D J Kupfer Journal: Depress Anxiety Date: 1999 Impact factor: 6.505
Authors: W D Taylor; D R McQuoid; A Ashley-Koch; J R MacFall; J Bridgers; R R Krishnan; D C Steffens Journal: Pharmacogenomics J Date: 2010-03-02 Impact factor: 3.550
Authors: Dennis S Charney; Charles F Reynolds; Lydia Lewis; Barry D Lebowitz; Trey Sunderland; George S Alexopoulos; Dan G Blazer; Ira R Katz; Barnett S Meyers; Patricia A Arean; Soo Borson; Charlotte Brown; Martha L Bruce; Christopher M Callahan; Mary E Charlson; Yeates Conwell; Bruce N Cuthbert; D P Devanand; Mary Jo Gibson; Gary L Gottlieb; K Ranga Krishnan; Sally K Laden; Constantine G Lyketsos; Benoit H Mulsant; George Niederehe; Jason T Olin; David W Oslin; Jane Pearson; Trudy Persky; Bruce G Pollock; Susan Raetzman; Mildred Reynolds; Carl Salzman; Richard Schulz; Thomas L Schwenk; Edward Scolnick; Jurgen Unutzer; Myrna M Weissman; Robert C Young Journal: Arch Gen Psychiatry Date: 2003-07
Authors: Timothy I Mueller; Robert Kohn; Nina Leventhal; Andrew C Leon; David Solomon; William Coryell; Jean Endicott; George S Alexopoulos; Martin B Keller Journal: Am J Geriatr Psychiatry Date: 2004 Jan-Feb Impact factor: 4.105
Authors: George S Alexopoulos; Kathleen Buckwalter; Jason Olin; Rick Martinez; Cynthia Wainscott; K Ranga R Krishnan Journal: Biol Psychiatry Date: 2002-09-15 Impact factor: 13.382
Authors: Jordan F Karp; Daniel J Buysse; Patricia R Houck; Christine Cherry; David J Kupfer; Ellen Frank Journal: Am J Psychiatry Date: 2004-10 Impact factor: 18.112
Authors: Meryl A Butters; Ellen M Whyte; Robert D Nebes; Amy E Begley; Mary Amanda Dew; Benoit H Mulsant; Michelle D Zmuda; Rishi Bhalla; Carolyn Cidis Meltzer; Bruce G Pollock; Charles F Reynolds; James T Becker Journal: Arch Gen Psychiatry Date: 2004-06
Authors: David C Steffens; Robert M Levy; Ryan Wagner; Douglas R McQuoid; K Ranga Rama Krishnan; Bernard J Carroll Journal: Am J Geriatr Psychiatry Date: 2002 Sep-Oct Impact factor: 4.105
Authors: Zahinoor Ismail; Eric E Smith; Yonas Geda; David Sultzer; Henry Brodaty; Gwenn Smith; Luis Agüera-Ortiz; Rob Sweet; David Miller; Constantine G Lyketsos Journal: Alzheimers Dement Date: 2015-06-18 Impact factor: 21.566
Authors: Jane L Eisen; Nicholas J Sibrava; Christina L Boisseau; Maria C Mancebo; Robert L Stout; Anthony Pinto; Steven A Rasmussen Journal: J Clin Psychiatry Date: 2013-03 Impact factor: 4.384
Authors: George S Alexopoulos; Patrick J Raue; Samprit Banerjee; Patricia Marino; Brenna N Renn; Nili Solomonov; Adenike Adeagbo; Jo Anne Sirey; Thomas D Hull; Dimitris N Kiosses; Elizabeth Mauer; Patricia A Areán Journal: Mol Psychiatry Date: 2020-07-01 Impact factor: 15.992